Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > OTC Transdermal Analgesic Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

OTC Transdermal Analgesic Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

OTC Transdermal Analgesic Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 136 Pages

Report ld: 3882251

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global market for OTC Transdermal Analgesic Patches was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for OTC Transdermal Analgesic Patches, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of OTC Transdermal Analgesic Patches by region & country, by Type, and by Application.

The OTC Transdermal Analgesic Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Transdermal Analgesic Patches.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • OTC Transdermal Analgesic Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  • Market Size Available for Years

  • 2025-2031

  • Global OTC Transdermal Analgesic Patches Companies Covered

  • Hisamitsu

    Mylan

    Johnson & Johnson

    Teva

    Lingrui

    Sanofi

    Qizheng

    Endo

    Huarun 999

    GSK

    Haw Par

    Nichiban

    Laboratoires Genevrier

    BLUE-EMU

    IBSA Group

    Pfizer

    Performance Health

    Actavis

    Teikoku Seiyaku

    Novartis

  • Global OTC Transdermal Analgesic Patches Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global OTC Transdermal Analgesic Patches Market, Segment by Type

  • Lidocaine Patches

    Diclofenac Patches

    Indomethacin Patches

    Counter-Irritant Patches

    Others

  • Global OTC Transdermal Analgesic Patches Market, Segment by Application

  • Pharmacy

    Clinic

    Others

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of OTC Transdermal Analgesic Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of OTC Transdermal Analgesic Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of OTC Transdermal Analgesic Patches in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 OTC Transdermal Analgesic Patches Product Introduction
    1.2 Global OTC Transdermal Analgesic Patches Market Size Forecast
        1.2.1 Global OTC Transdermal Analgesic Patches Sales Value (2020-2031)
        1.2.2 Global OTC Transdermal Analgesic Patches Sales Volume (2020-2031)
        1.2.3 Global OTC Transdermal Analgesic Patches Sales Price (2020-2031)
    1.3 OTC Transdermal Analgesic Patches Market Trends & Drivers
        1.3.1 OTC Transdermal Analgesic Patches Industry Trends
        1.3.2 OTC Transdermal Analgesic Patches Market Drivers & Opportunity
        1.3.3 OTC Transdermal Analgesic Patches Market Challenges
        1.3.4 OTC Transdermal Analgesic Patches Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered
2 Competitive Analysis by Company
    2.1 Global OTC Transdermal Analgesic Patches Players Revenue Ranking (2024)
    2.2 Global OTC Transdermal Analgesic Patches Revenue by Company (2020-2025)
    2.3 Global OTC Transdermal Analgesic Patches Players Sales Volume Ranking (2024)
    2.4 Global OTC Transdermal Analgesic Patches Sales Volume by Company Players (2020-2025)
    2.5 Global OTC Transdermal Analgesic Patches Average Price by Company (2020-2025)
    2.6 Key Manufacturers OTC Transdermal Analgesic Patches Manufacturing Base and Headquarters
    2.7 Key Manufacturers OTC Transdermal Analgesic Patches Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of OTC Transdermal Analgesic Patches
    2.9 OTC Transdermal Analgesic Patches Market Competitive Analysis
        2.9.1 OTC Transdermal Analgesic Patches Market Concentration Rate (2020-2025)
        2.9.2 Global 5 and 10 Largest Manufacturers by OTC Transdermal Analgesic Patches Revenue in 2024
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Transdermal Analgesic Patches as of 2024)
    2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Lidocaine Patches
        3.1.2 Diclofenac Patches
        3.1.3 Indomethacin Patches
        3.1.4 Counter-Irritant Patches
        3.1.5 Others
    3.2 Global OTC Transdermal Analgesic Patches Sales Value by Type
        3.2.1 Global OTC Transdermal Analgesic Patches Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global OTC Transdermal Analgesic Patches Sales Value, by Type (2020-2031)
        3.2.3 Global OTC Transdermal Analgesic Patches Sales Value, by Type (%) (2020-2031)
    3.3 Global OTC Transdermal Analgesic Patches Sales Volume by Type
        3.3.1 Global OTC Transdermal Analgesic Patches Sales Volume by Type (2020 VS 2024 VS 2031)
        3.3.2 Global OTC Transdermal Analgesic Patches Sales Volume, by Type (2020-2031)
        3.3.3 Global OTC Transdermal Analgesic Patches Sales Volume, by Type (%) (2020-2031)
    3.4 Global OTC Transdermal Analgesic Patches Average Price by Type (2020-2031)
4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmacy
        4.1.2 Clinic
        4.1.3 Others
    4.2 Global OTC Transdermal Analgesic Patches Sales Value by Application
        4.2.1 Global OTC Transdermal Analgesic Patches Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global OTC Transdermal Analgesic Patches Sales Value, by Application (2020-2031)
        4.2.3 Global OTC Transdermal Analgesic Patches Sales Value, by Application (%) (2020-2031)
    4.3 Global OTC Transdermal Analgesic Patches Sales Volume by Application
        4.3.1 Global OTC Transdermal Analgesic Patches Sales Volume by Application (2020 VS 2024 VS 2031)
        4.3.2 Global OTC Transdermal Analgesic Patches Sales Volume, by Application (2020-2031)
        4.3.3 Global OTC Transdermal Analgesic Patches Sales Volume, by Application (%) (2020-2031)
    4.4 Global OTC Transdermal Analgesic Patches Average Price by Application (2020-2031)
5 Segmentation by Region
    5.1 Global OTC Transdermal Analgesic Patches Sales Value by Region
        5.1.1 Global OTC Transdermal Analgesic Patches Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global OTC Transdermal Analgesic Patches Sales Value by Region (2020-2025)
        5.1.3 Global OTC Transdermal Analgesic Patches Sales Value by Region (2026-2031)
        5.1.4 Global OTC Transdermal Analgesic Patches Sales Value by Region (%), (2020-2031)
    5.2 Global OTC Transdermal Analgesic Patches Sales Volume by Region
        5.2.1 Global OTC Transdermal Analgesic Patches Sales Volume by Region: 2020 VS 2024 VS 2031
        5.2.2 Global OTC Transdermal Analgesic Patches Sales Volume by Region (2020-2025)
        5.2.3 Global OTC Transdermal Analgesic Patches Sales Volume by Region (2026-2031)
        5.2.4 Global OTC Transdermal Analgesic Patches Sales Volume by Region (%), (2020-2031)
    5.3 Global OTC Transdermal Analgesic Patches Average Price by Region (2020-2031)
    5.4 North America
        5.4.1 North America OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        5.4.2 North America OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
    5.5 Europe
        5.5.1 Europe OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        5.5.2 Europe OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
    5.6 Asia Pacific
        5.6.1 Asia Pacific OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        5.6.2 Asia Pacific OTC Transdermal Analgesic Patches Sales Value by Region (%), 2024 VS 2031
    5.7 South America
        5.7.1 South America OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        5.7.2 South America OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        5.8.2 Middle East & Africa OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value
        6.2.1 Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.2.2 Key Countries/Regions OTC Transdermal Analgesic Patches Sales Volume, 2020-2031
    6.3 United States
        6.3.1 United States OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.3.2 United States OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.4.2 Europe OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.5.2 China OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.5.3 China OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.6.2 Japan OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.7.2 South Korea OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.8.2 Southeast Asia OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India OTC Transdermal Analgesic Patches Sales Value, 2020-2031
        6.9.2 India OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
        6.9.3 India OTC Transdermal Analgesic Patches Sales Value by Application, 2024 VS 2031
7 Company Profiles
    7.1 Hisamitsu
        7.1.1 Hisamitsu Company Information
        7.1.2 Hisamitsu Introduction and Business Overview
        7.1.3 Hisamitsu OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.1.4 Hisamitsu OTC Transdermal Analgesic Patches Product Offerings
        7.1.5 Hisamitsu Recent Development
    7.2 Mylan
        7.2.1 Mylan Company Information
        7.2.2 Mylan Introduction and Business Overview
        7.2.3 Mylan OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.2.4 Mylan OTC Transdermal Analgesic Patches Product Offerings
        7.2.5 Mylan Recent Development
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Information
        7.3.2 Johnson & Johnson Introduction and Business Overview
        7.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Product Offerings
        7.3.5 Johnson & Johnson Recent Development
    7.4 Teva
        7.4.1 Teva Company Information
        7.4.2 Teva Introduction and Business Overview
        7.4.3 Teva OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.4.4 Teva OTC Transdermal Analgesic Patches Product Offerings
        7.4.5 Teva Recent Development
    7.5 Lingrui
        7.5.1 Lingrui Company Information
        7.5.2 Lingrui Introduction and Business Overview
        7.5.3 Lingrui OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.5.4 Lingrui OTC Transdermal Analgesic Patches Product Offerings
        7.5.5 Lingrui Recent Development
    7.6 Sanofi
        7.6.1 Sanofi Company Information
        7.6.2 Sanofi Introduction and Business Overview
        7.6.3 Sanofi OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.6.4 Sanofi OTC Transdermal Analgesic Patches Product Offerings
        7.6.5 Sanofi Recent Development
    7.7 Qizheng
        7.7.1 Qizheng Company Information
        7.7.2 Qizheng Introduction and Business Overview
        7.7.3 Qizheng OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.7.4 Qizheng OTC Transdermal Analgesic Patches Product Offerings
        7.7.5 Qizheng Recent Development
    7.8 Endo
        7.8.1 Endo Company Information
        7.8.2 Endo Introduction and Business Overview
        7.8.3 Endo OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.8.4 Endo OTC Transdermal Analgesic Patches Product Offerings
        7.8.5 Endo Recent Development
    7.9 Huarun 999
        7.9.1 Huarun 999 Company Information
        7.9.2 Huarun 999 Introduction and Business Overview
        7.9.3 Huarun 999 OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.9.4 Huarun 999 OTC Transdermal Analgesic Patches Product Offerings
        7.9.5 Huarun 999 Recent Development
    7.10 GSK
        7.10.1 GSK Company Information
        7.10.2 GSK Introduction and Business Overview
        7.10.3 GSK OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.10.4 GSK OTC Transdermal Analgesic Patches Product Offerings
        7.10.5 GSK Recent Development
    7.11 Haw Par
        7.11.1 Haw Par Company Information
        7.11.2 Haw Par Introduction and Business Overview
        7.11.3 Haw Par OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.11.4 Haw Par OTC Transdermal Analgesic Patches Product Offerings
        7.11.5 Haw Par Recent Development
    7.12 Nichiban
        7.12.1 Nichiban Company Information
        7.12.2 Nichiban Introduction and Business Overview
        7.12.3 Nichiban OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.12.4 Nichiban OTC Transdermal Analgesic Patches Product Offerings
        7.12.5 Nichiban Recent Development
    7.13 Laboratoires Genevrier
        7.13.1 Laboratoires Genevrier Company Information
        7.13.2 Laboratoires Genevrier Introduction and Business Overview
        7.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product Offerings
        7.13.5 Laboratoires Genevrier Recent Development
    7.14 BLUE-EMU
        7.14.1 BLUE-EMU Company Information
        7.14.2 BLUE-EMU Introduction and Business Overview
        7.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Product Offerings
        7.14.5 BLUE-EMU Recent Development
    7.15 IBSA Group
        7.15.1 IBSA Group Company Information
        7.15.2 IBSA Group Introduction and Business Overview
        7.15.3 IBSA Group OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.15.4 IBSA Group OTC Transdermal Analgesic Patches Product Offerings
        7.15.5 IBSA Group Recent Development
    7.16 Pfizer
        7.16.1 Pfizer Company Information
        7.16.2 Pfizer Introduction and Business Overview
        7.16.3 Pfizer OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.16.4 Pfizer OTC Transdermal Analgesic Patches Product Offerings
        7.16.5 Pfizer Recent Development
    7.17 Performance Health
        7.17.1 Performance Health Company Information
        7.17.2 Performance Health Introduction and Business Overview
        7.17.3 Performance Health OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.17.4 Performance Health OTC Transdermal Analgesic Patches Product Offerings
        7.17.5 Performance Health Recent Development
    7.18 Actavis
        7.18.1 Actavis Company Information
        7.18.2 Actavis Introduction and Business Overview
        7.18.3 Actavis OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.18.4 Actavis OTC Transdermal Analgesic Patches Product Offerings
        7.18.5 Actavis Recent Development
    7.19 Teikoku Seiyaku
        7.19.1 Teikoku Seiyaku Company Information
        7.19.2 Teikoku Seiyaku Introduction and Business Overview
        7.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product Offerings
        7.19.5 Teikoku Seiyaku Recent Development
    7.20 Novartis
        7.20.1 Novartis Company Information
        7.20.2 Novartis Introduction and Business Overview
        7.20.3 Novartis OTC Transdermal Analgesic Patches Sales, Revenue, Price and Gross Margin (2020-2025)
        7.20.4 Novartis OTC Transdermal Analgesic Patches Product Offerings
        7.20.5 Novartis Recent Development
8 Industry Chain Analysis
    8.1 OTC Transdermal Analgesic Patches Industrial Chain
    8.2 OTC Transdermal Analgesic Patches Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 OTC Transdermal Analgesic Patches Sales Model
        8.5.2 Sales Channel
        8.5.3 OTC Transdermal Analgesic Patches Distributors
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. OTC Transdermal Analgesic Patches Market Trends
 Table 2. OTC Transdermal Analgesic Patches Market Drivers & Opportunity
 Table 3. OTC Transdermal Analgesic Patches Market Challenges
 Table 4. OTC Transdermal Analgesic Patches Market Restraints
 Table 5. Global OTC Transdermal Analgesic Patches Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global OTC Transdermal Analgesic Patches Revenue Market Share by Company (2020-2025)
 Table 7. Global OTC Transdermal Analgesic Patches Sales Volume by Company (2020-2025) & (K Units)
 Table 8. Global OTC Transdermal Analgesic Patches Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market OTC Transdermal Analgesic Patches Price by Company (2020-2025) & (US$/Unit)
 Table 10. Key Manufacturers OTC Transdermal Analgesic Patches Manufacturing Base and Headquarters
 Table 11. Key Manufacturers OTC Transdermal Analgesic Patches Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of OTC Transdermal Analgesic Patches
 Table 13. Global OTC Transdermal Analgesic Patches Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Transdermal Analgesic Patches as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global OTC Transdermal Analgesic Patches Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global OTC Transdermal Analgesic Patches Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global OTC Transdermal Analgesic Patches Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global OTC Transdermal Analgesic Patches Sales Market Share in Value by Type (2020-2025)
 Table 20. Global OTC Transdermal Analgesic Patches Sales Market Share in Value by Type (2026-2031)
 Table 21. Global OTC Transdermal Analgesic Patches Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
 Table 22. Global OTC Transdermal Analgesic Patches Sales Volume by Type (2020-2025) & (K Units)
 Table 23. Global OTC Transdermal Analgesic Patches Sales Volume by Type (2026-2031) & (K Units)
 Table 24. Global OTC Transdermal Analgesic Patches Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global OTC Transdermal Analgesic Patches Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global OTC Transdermal Analgesic Patches Price by Type (2020-2025) & (US$/Unit)
 Table 27. Global OTC Transdermal Analgesic Patches Price by Type (2026-2031) & (US$/Unit)
 Table 28. Global OTC Transdermal Analgesic Patches Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global OTC Transdermal Analgesic Patches Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global OTC Transdermal Analgesic Patches Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global OTC Transdermal Analgesic Patches Sales Market Share in Value by Application (2020-2025)
 Table 32. Global OTC Transdermal Analgesic Patches Sales Market Share in Value by Application (2026-2031)
 Table 33. Global OTC Transdermal Analgesic Patches Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
 Table 34. Global OTC Transdermal Analgesic Patches Sales Volume by Application (2020-2025) & (K Units)
 Table 35. Global OTC Transdermal Analgesic Patches Sales Volume by Application (2026-2031) & (K Units)
 Table 36. Global OTC Transdermal Analgesic Patches Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global OTC Transdermal Analgesic Patches Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global OTC Transdermal Analgesic Patches Price by Application (2020-2025) & (US$/Unit)
 Table 39. Global OTC Transdermal Analgesic Patches Price by Application (2026-2031) & (US$/Unit)
 Table 40. Global OTC Transdermal Analgesic Patches Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global OTC Transdermal Analgesic Patches Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global OTC Transdermal Analgesic Patches Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global OTC Transdermal Analgesic Patches Sales Value by Region (2020-2025) & (%)
 Table 44. Global OTC Transdermal Analgesic Patches Sales Value by Region (2026-2031) & (%)
 Table 45. Global OTC Transdermal Analgesic Patches Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
 Table 46. Global OTC Transdermal Analgesic Patches Sales Volume by Region (2020-2025) & (K Units)
 Table 47. Global OTC Transdermal Analgesic Patches Sales Volume by Region (2026-2031) & (K Units)
 Table 48. Global OTC Transdermal Analgesic Patches Sales Volume by Region (2020-2025) & (%)
 Table 49. Global OTC Transdermal Analgesic Patches Sales Volume by Region (2026-2031) & (%)
 Table 50. Global OTC Transdermal Analgesic Patches Average Price by Region (2020-2025) & (US$/Unit)
 Table 51. Global OTC Transdermal Analgesic Patches Average Price by Region (2026-2031) & (US$/Unit)
 Table 52. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Volume, (2020-2025) & (K Units)
 Table 56. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Volume, (2026-2031) & (K Units)
 Table 57. Hisamitsu Company Information
 Table 58. Hisamitsu Introduction and Business Overview
 Table 59. Hisamitsu OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 60. Hisamitsu OTC Transdermal Analgesic Patches Product Offerings
 Table 61. Hisamitsu Recent Development
 Table 62. Mylan Company Information
 Table 63. Mylan Introduction and Business Overview
 Table 64. Mylan OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 65. Mylan OTC Transdermal Analgesic Patches Product Offerings
 Table 66. Mylan Recent Development
 Table 67. Johnson & Johnson Company Information
 Table 68. Johnson & Johnson Introduction and Business Overview
 Table 69. Johnson & Johnson OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 70. Johnson & Johnson OTC Transdermal Analgesic Patches Product Offerings
 Table 71. Johnson & Johnson Recent Development
 Table 72. Teva Company Information
 Table 73. Teva Introduction and Business Overview
 Table 74. Teva OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Teva OTC Transdermal Analgesic Patches Product Offerings
 Table 76. Teva Recent Development
 Table 77. Lingrui Company Information
 Table 78. Lingrui Introduction and Business Overview
 Table 79. Lingrui OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Lingrui OTC Transdermal Analgesic Patches Product Offerings
 Table 81. Lingrui Recent Development
 Table 82. Sanofi Company Information
 Table 83. Sanofi Introduction and Business Overview
 Table 84. Sanofi OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Sanofi OTC Transdermal Analgesic Patches Product Offerings
 Table 86. Sanofi Recent Development
 Table 87. Qizheng Company Information
 Table 88. Qizheng Introduction and Business Overview
 Table 89. Qizheng OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Qizheng OTC Transdermal Analgesic Patches Product Offerings
 Table 91. Qizheng Recent Development
 Table 92. Endo Company Information
 Table 93. Endo Introduction and Business Overview
 Table 94. Endo OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 95. Endo OTC Transdermal Analgesic Patches Product Offerings
 Table 96. Endo Recent Development
 Table 97. Huarun 999 Company Information
 Table 98. Huarun 999 Introduction and Business Overview
 Table 99. Huarun 999 OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 100. Huarun 999 OTC Transdermal Analgesic Patches Product Offerings
 Table 101. Huarun 999 Recent Development
 Table 102. GSK Company Information
 Table 103. GSK Introduction and Business Overview
 Table 104. GSK OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 105. GSK OTC Transdermal Analgesic Patches Product Offerings
 Table 106. GSK Recent Development
 Table 107. Haw Par Company Information
 Table 108. Haw Par Introduction and Business Overview
 Table 109. Haw Par OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 110. Haw Par OTC Transdermal Analgesic Patches Product Offerings
 Table 111. Haw Par Recent Development
 Table 112. Nichiban Company Information
 Table 113. Nichiban Introduction and Business Overview
 Table 114. Nichiban OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 115. Nichiban OTC Transdermal Analgesic Patches Product Offerings
 Table 116. Nichiban Recent Development
 Table 117. Laboratoires Genevrier Company Information
 Table 118. Laboratoires Genevrier Introduction and Business Overview
 Table 119. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 120. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product Offerings
 Table 121. Laboratoires Genevrier Recent Development
 Table 122. BLUE-EMU Company Information
 Table 123. BLUE-EMU Introduction and Business Overview
 Table 124. BLUE-EMU OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 125. BLUE-EMU OTC Transdermal Analgesic Patches Product Offerings
 Table 126. BLUE-EMU Recent Development
 Table 127. IBSA Group Company Information
 Table 128. IBSA Group Introduction and Business Overview
 Table 129. IBSA Group OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 130. IBSA Group OTC Transdermal Analgesic Patches Product Offerings
 Table 131. IBSA Group Recent Development
 Table 132. Pfizer Company Information
 Table 133. Pfizer Introduction and Business Overview
 Table 134. Pfizer OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 135. Pfizer OTC Transdermal Analgesic Patches Product Offerings
 Table 136. Pfizer Recent Development
 Table 137. Performance Health Company Information
 Table 138. Performance Health Introduction and Business Overview
 Table 139. Performance Health OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 140. Performance Health OTC Transdermal Analgesic Patches Product Offerings
 Table 141. Performance Health Recent Development
 Table 142. Actavis Company Information
 Table 143. Actavis Introduction and Business Overview
 Table 144. Actavis OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 145. Actavis OTC Transdermal Analgesic Patches Product Offerings
 Table 146. Actavis Recent Development
 Table 147. Teikoku Seiyaku Company Information
 Table 148. Teikoku Seiyaku Introduction and Business Overview
 Table 149. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 150. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product Offerings
 Table 151. Teikoku Seiyaku Recent Development
 Table 152. Novartis Company Information
 Table 153. Novartis Introduction and Business Overview
 Table 154. Novartis OTC Transdermal Analgesic Patches Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 155. Novartis OTC Transdermal Analgesic Patches Product Offerings
 Table 156. Novartis Recent Development
 Table 157. Key Raw Materials Lists
 Table 158. Raw Materials Key Suppliers Lists
 Table 159. OTC Transdermal Analgesic Patches Downstream Customers
 Table 160. OTC Transdermal Analgesic Patches Distributors List
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources


List of Figures
 Figure 1. OTC Transdermal Analgesic Patches Product Picture
 Figure 2. Global OTC Transdermal Analgesic Patches Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global OTC Transdermal Analgesic Patches Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global OTC Transdermal Analgesic Patches Sales Volume (2020-2031) & (K Units)
 Figure 5. Global OTC Transdermal Analgesic Patches Sales Price (2020-2031) & (US$/Unit)
 Figure 6. OTC Transdermal Analgesic Patches Report Years Considered
 Figure 7. Global OTC Transdermal Analgesic Patches Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global OTC Transdermal Analgesic Patches Players Sales Volume Ranking (2024) & (K Units)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by OTC Transdermal Analgesic Patches Revenue in 2024
 Figure 10. OTC Transdermal Analgesic Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Lidocaine Patches Picture
 Figure 12. Diclofenac Patches Picture
 Figure 13. Indomethacin Patches Picture
 Figure 14. Counter-Irritant Patches Picture
 Figure 15. Others Picture
 Figure 16. Global OTC Transdermal Analgesic Patches Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 17. Global OTC Transdermal Analgesic Patches Sales Value Market Share by Type, 2024 & 2031
 Figure 18. Global OTC Transdermal Analgesic Patches Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
 Figure 19. Global OTC Transdermal Analgesic Patches Sales Volume Market Share by Type, 2024 & 2031
 Figure 20. Global OTC Transdermal Analgesic Patches Price by Type (2020-2031) & (US$/Unit)
 Figure 21. Product Picture of Pharmacy
 Figure 22. Product Picture of Clinic
 Figure 23. Product Picture of Others
 Figure 24. Global OTC Transdermal Analgesic Patches Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 25. Global OTC Transdermal Analgesic Patches Sales Value Market Share by Application, 2024 & 2031
 Figure 26. Global OTC Transdermal Analgesic Patches Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
 Figure 27. Global OTC Transdermal Analgesic Patches Sales Volume Market Share by Application, 2024 & 2031
 Figure 28. Global OTC Transdermal Analgesic Patches Price by Application (2020-2031) & (US$/Unit)
 Figure 29. North America OTC Transdermal Analgesic Patches Sales Value (2020-2031) & (US$ Million)
 Figure 30. North America OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
 Figure 31. Europe OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 32. Europe OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
 Figure 33. Asia Pacific OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific OTC Transdermal Analgesic Patches Sales Value by Region (%), 2024 VS 2031
 Figure 35. South America OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 36. South America OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
 Figure 37. Middle East & Africa OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 38. Middle East & Africa OTC Transdermal Analgesic Patches Sales Value by Country (%), 2024 VS 2031
 Figure 39. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Value (%), (2020-2031)
 Figure 40. Key Countries/Regions OTC Transdermal Analgesic Patches Sales Volume (%), (2020-2031)
 Figure 41. United States OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 42. United States OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 43. United States OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 44. Europe OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 45. Europe OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 46. Europe OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 47. China OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 48. China OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 49. China OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 50. Japan OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 51. Japan OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 52. Japan OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 53. South Korea OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 54. South Korea OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 55. South Korea OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 56. Southeast Asia OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 57. Southeast Asia OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 58. Southeast Asia OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 59. India OTC Transdermal Analgesic Patches Sales Value, (2020-2031) & (US$ Million)
 Figure 60. India OTC Transdermal Analgesic Patches Sales Value by Type (%), 2024 VS 2031
 Figure 61. India OTC Transdermal Analgesic Patches Sales Value by Application (%), 2024 VS 2031
 Figure 62. OTC Transdermal Analgesic Patches Industrial Chain
 Figure 63. OTC Transdermal Analgesic Patches Manufacturing Cost Structure
 Figure 64. Channels of Distribution (Direct Sales, and Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed

Description

The global market for OTC Transdermal Analgesic Patches was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for OTC Transdermal Analgesic Patches, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of OTC Transdermal Analgesic Patches by region & country, by Type, and by Application.

The OTC Transdermal Analgesic Patches market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Transdermal Analgesic Patches.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of OTC Transdermal Analgesic Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of OTC Transdermal Analgesic Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of OTC Transdermal Analgesic Patches in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Related Reports

OTC Transdermal Analgesic Patches- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 136 Pages

Report ld: 3882251

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 3950.00

tip

USD 5925.00

tip

USD 7900.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now